L. Franks

发表

Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development

A. Radomińska-Pandya, P. Prather, Benjamin M. Ford, 2016, PloS one.

Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.

J. Douglas, T. Prisinzano, T. Vasiljevik, 2013, Journal of medicinal chemistry.

Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development.

S. Mu, P. Prather, Alicja Urbaniak, 2021, Life sciences.

Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development

P. Crooks, Edward L. Stahl, Narsimha R Penthala, 2017, Pharmacological research.

Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC

R. Fujiwara, L. James, W. Fantegrossi, 2018, Front. Pharmacol..

Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.

P. Prather, L. Franks, J. Moran, 2013, Toxicology and applied pharmacology.

AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies

Kathryn A. Seely, W. Fantegrossi, P. Prather, 2012, Neuropharmacology.

Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein–Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018

P. Crooks, Narsimha R Penthala, W. Fantegrossi, 2019, The Journal of Pharmacology and Experimental Therapeutics.

Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.

T. Vasiljevik, W. Fantegrossi, P. Prather, 2015, Pharmacological research.

The tamoxifen derivative ridaifen‐B is a high affinity selective CB2 receptor inverse agonist exhibiting anti‐inflammatory and anti‐osteoclastogenic effects

Haibo Zhao, P. Prather, Benjamin M. Ford, 2018, Toxicology and applied pharmacology.

CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.

P. Prather, S. Bratton, Benjamin M. Ford, 2013, Biochemical and biophysical research communications.

Characterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogs.

P. Crooks, Narsimha R Penthala, P. Prather, 2014, European journal of pharmacology.

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity

P. Prather, Benjamin M. Ford, L. Franks, 2016, Front. Pharmacol..